Skip to content

The impact of Module Continence Aids on costs and quality of life in patients with urine incontinence

The impact of Module Continence Aids on costs and quality of life in patients with urine incontinence

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON23307
Enrollment
600
Registered
2019-02-28
Start date
2019-05-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urine-incontinence

Interventions

None listed

Sponsors

ZonMW
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who already use continence aids, provided by the pharmacy (or national operating supplier).

Exclusion criteria

Exclusion criteria: - Patients with fecal incontinence as only kind of incontinence. - Patients who already have had a prescription according to the new Module CH.

Design outcomes

Primary

MeasureTime frame
- Use of continence aids - Functioning of the patient - Costs related to urine incontinence

Contacts

Public ContactMiranda Schreuder

UMCG

m.c.schreuder@umcg.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)